Effectiveness of pneumococcal vaccination campaigns in humanitarian settings: A modelling study
PLOS Medicine · 11.11.2026 · 23 (11) · e1004768
DOI: 10.1371/journal.pmed.1004768 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 11.11.2026. Verfasst von Kevin van Zandvoort und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Elrha, Department for International Development, UK Government, Wellcome Trust.
Abstract (Originalsprache)
Background A large and increasing number of people are forcibly displaced worldwide because of war, food insecurity, and other crises. Streptococcus pneumoniae likely causes a substantial health burden in crisis-affected populations. Pneumococcal conjugate vaccines (PCVs) are widely used in routine immunisation programmes, including through the Essential Programme on Immunization (EPI) to protect against pneumococcal disease. They are typically administered as a three-dose schedule, either as three doses in early infancy or two doses in infancy followed by a booster at 9–18 months of age. However, PCVs are rarely used in humanitarian responses. We evaluated the potential impact of logistically feasible PCV campaigns in such settings. Methods and findings We conducted a pneumococcal carriage, malnutrition, and social contact survey in a camp for displaced people near Hargeisa, Somaliland, to parameterise a transmission model accounting for migration. We projected the effect of PCV mass-vaccination campaigns using one or two doses and vaccinating children
Autor:innen und Institutionen
- Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Health and Nutrition, Save the Children International, Hargeisa, Somaliland.
- Republic of Somaliland Ministry of Health Development, Hargeisa, Somaliland.
- Save the Children, London, United Kingdom.
- Infection, Immunity and Global Health, Murdoch Children's Research Institute, The University of Melbourne Department of Paediatrics at the Royal Children's Hospital, Melbourne, Australia.
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
ORCID-Profile: Kevin van Zandvoort, Abdihamid Warsame, Casey L Pell, Catherine R McGowan, E Kim Mulholland, Catherine Satzke, Rosalind M Eggo, Francesco Checchi, Stefan Flasche
Förderung
- Elrha
- Department for International Development, UK Government
- Wellcome Trust
- National Institute for Health and Care Research
- Royal Society
- State Government of Victoria
Zitieren
APA
van Zandvoort, K., Bobe, M. O., Hassan, A. I., Cummings, R., Warsame, A., Pell, C. L., Abdi, M. I., Ibrahim, S., McGowan, C. R., Mulholland, E. K., Satzke, C., Eggo, R. M., Hergeye, M. A., Checchi, F., & Flasche, S. (2026). Effectiveness of pneumococcal vaccination campaigns in humanitarian settings: A modelling study. PLOS Medicine, 23(11), e1004768. https://doi.org/10.1371/journal.pmed.1004768
Vancouver
van Zandvoort K, Bobe MO, Hassan AI, Cummings R, Warsame A, Pell CL, et al. Effectiveness of pneumococcal vaccination campaigns in humanitarian settings: A modelling study. PLOS Medicine. 2026;23(11):e1004768. doi:10.1371/journal.pmed.1004768
BibTeX
@article{vanZandvoort2026,
author = {van Zandvoort, Kevin and Bobe, Mohamed O and Hassan, Abdirahman I and Cummings, Rachael and Warsame, Abdihamid and Pell, Casey L and Abdi, Mohamed Ismail and Ibrahim, Saed and McGowan, Catherine R and Mulholland, E Kim and Satzke, Catherine and Eggo, Rosalind M and Hergeye, Mohamed Abdi and Checchi, Francesco and Flasche, Stefan},
title = {Effectiveness of pneumococcal vaccination campaigns in humanitarian settings: A modelling study},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {11},
pages = {e1004768},
doi = {10.1371/journal.pmed.1004768}
}
EUVIMED